MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2018-06-18
DOI
10.1080/10428194.2018.1461861
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia
- (2017) Hamed Mirzaei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia
- (2017) Christos K. Kontos et al. LEUKEMIA RESEARCH
- MicroRNA-17~92 inhibits colorectal cancer progression by targeting angiogenesis
- (2016) Huabin Ma et al. CANCER LETTERS
- miR‐17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia‐Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation
- (2016) Tianji Chen et al. Journal of the American Heart Association
- KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia
- (2015) Panagiotis G. Adamopoulos et al. CLINICAL BIOCHEMISTRY
- Role of microRNA in chronic lymphocytic leukemia onset and progression
- (2015) Veronica Balatti et al. Journal of Hematology & Oncology
- Unknown
- (2015) Basile Stamatopoulos et al. MOLECULAR MEDICINE
- Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis
- (2015) Laura Smith et al. PLoS One
- MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma
- (2015) Ye Song et al. Oncotarget
- HLA-G Expression as a Prognostic Indicator in B-Cell Chronic Lymphocytic Leukemia
- (2014) Mohamed A. Attia et al. ACTA HAEMATOLOGICA
- Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
- (2014) N. Pflug et al. BLOOD
- Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia
- (2014) Marietta S. Truger et al. BRITISH JOURNAL OF HAEMATOLOGY
- Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients
- (2014) Michaël Van Damme et al. Epigenetics
- DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasia
- (2014) Hung-Cheng Lai et al. GYNECOLOGIC ONCOLOGY
- Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia
- (2014) Marie-Christine Kyrtsonis et al. Biomed Research International
- Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go
- (2014) Anna Puiggros et al. Biomed Research International
- SF3B1 mutations in chronic lymphocytic leukemia
- (2013) Y. Wan et al. BLOOD
- The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
- (2013) E Mogilyansky et al. CELL DEATH AND DIFFERENTIATION
- Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes
- (2012) Diamantina Vasilatou et al. LEUKEMIA RESEARCH
- Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2011) B. Eichhorst et al. ANNALS OF ONCOLOGY
- A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer
- (2011) Yijun Chen et al. ANNALS OF SURGICAL ONCOLOGY
- Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
- (2011) D. Rossi et al. BLOOD
- The Novel Member of the BCL2 Gene Family, BCL2L12, Is Substantially Elevated in Chronic Lymphocytic Leukemia Patients, Supporting Its Value As a Significant Biomarker
- (2011) S. G. Papageorgiou et al. ONCOLOGIST
- Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma
- (2011) Kazuma Ohyashiki et al. PLoS One
- MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells
- (2011) Shuqiang Li et al. PLoS One
- The role of microRNAs in normal and malignant hematopoiesis
- (2009) Diamantina Vasilatou et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients
- (2009) Masami Tanaka et al. PLoS One
- Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up
- (2008) T. Zenz et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- New prognostic markers in chronic lymphocytic leukemia
- (2008) Carol Moreno et al. BLOOD REVIEWS
- Identification of Hypoxia-Inducible Factor-1 as a Novel Target for miR-17-92 MicroRNA Cluster
- (2008) A. Taguchi et al. CANCER RESEARCH
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started